ARK Genomic Revolution ETF (ARKG)

CBOE · US Equities - Industry Sector · USA

Are the companies inside ARKG undervalued?

The companies inside ARKG trade 183% above what we estimate they are worth. We could give a verdict on 88% of the fund's weight: 33 holdings as reported to the SEC at 31 Jul 2026.

Where the money is: 3% in companies in the buy zone, 1% about fairly valued, 85% overvalued, 12% without a verdict.

What does ARKG hold?

The ten largest holdings, with our verdict on each:

How much does the ARKG fee cost?

Its expense ratio is 0.75% a year: on $10,000 held flat that is $750 over 10 years and $1,500 over 20.

Browse

Other US Equities - Industry Sector ETFs